📰 AQST Latest News

Last Updated: 2026.04.07 14:07:58
Recent Headlines
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
GlobeNewsWire 2026-04-07 2:07 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST
GlobeNewsWire 2026-04-07 8:15 PM
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
GlobeNewsWire 2026-03-26 7:20 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST
PRNewswire 2026-03-26 2:00 PM
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors
GlobeNewsWire 2026-03-26 1:00 PM
AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt
PRNewswire 2026-03-26 1:00 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST
GlobeNewsWire 2026-03-24 8:20 PM
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky
BusinessWire 2026-03-24 8:00 PM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)
GlobeNewsWire 2026-03-24 12:45 PM
Robbins LLP Urges AQST Stockholders Who Lost Money Investing in Aquestive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
PRNewswire 2026-03-24 2:31 AM
Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
GlobeNewsWire 2026-02-25 12:00 PM
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
GlobeNewsWire 2026-02-24 12:00 PM